InnovAge Holding Corp. Proceeds from (Repurchase of) Equity
InnovAge Holding Corp. (INNV) reported Proceeds from (Repurchase of) Equity of $0 for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfEquity · last filed 2026-09-09
- InnovAge Holding Corp. proceeds from (repurchase of) equity for the quarter ending 2026-06-30 was $0.00.
- InnovAge Holding Corp. proceeds from (repurchase of) equity for the quarter ending 2026-03-31 was $0.00.
- InnovAge Holding Corp. proceeds from (repurchase of) equity for the quarter ending 2025-12-31 was $0.00.
- InnovAge Holding Corp. proceeds from (repurchase of) equity for the quarter ending 2025-09-30 was $0.00.
- InnovAge Holding Corp. proceeds from (repurchase of) equity for fiscal 2026 was $0.00.
- InnovAge Holding Corp. proceeds from (repurchase of) equity for fiscal 2025 was -$7.32M.
- InnovAge Holding Corp. proceeds from (repurchase of) equity for fiscal 2024 was -$179.00K.
- InnovAge Holding Corp. proceeds from (repurchase of) equity for fiscal 2023 was $0.00.
| Period end | Proceeds from (Repurchase of) Equity 3 month | Proceeds from (Repurchase of) Equity 6 month | Proceeds from (Repurchase of) Equity 9 month | Proceeds from (Repurchase of) Equity 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $0.00 derived: sum of 2 quarters · filed 2026-09-09 | $0.00 derived: sum of 3 quarters · filed 2026-09-09 | $0.00 10-K · filed 2026-09-09 |
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 10-Q · filed 2026-05-08 | -$297.00K derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | $0.00 10-Q · filed 2026-02-03 | -$297.00K derived: sum of 3 quarters · filed 2026-09-09 | -$1.41M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | -$297.00K derived: sum of 2 quarters · filed 2026-09-09 | -$1.41M derived: sum of 3 quarters · filed 2026-09-09 | -$2.50M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$1.41M derived: sum of 2 quarters · filed 2026-09-09 | -$2.50M derived: sum of 3 quarters · filed 2026-09-09 | -$7.32M 10-K · filed 2026-09-09 |
| 2025-03-31 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$2.20M derived: sum of 2 quarters · filed 2026-05-08 | -$7.02M 10-Q · filed 2026-05-08 | -$7.20M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-03 | -$5.91M 10-Q · filed 2026-02-03 | -$6.09M derived: sum of 3 quarters · filed 2026-02-03 | -$6.09M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$4.82M 10-Q · filed 2025-11-04 | -$5.00M derived: sum of 2 quarters · filed 2025-11-04 | -$5.00M derived: sum of 3 quarters · filed 2025-11-04 | -$5.00M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$179.00K derived: sum of 2 quarters · filed 2025-09-09 | -$179.00K derived: sum of 3 quarters · filed 2025-09-09 | -$179.00K 10-K · filed 2025-09-09 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-05-06 | $0.00 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $0.00 10-Q · filed 2025-02-04 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-05 | |||
| 2023-06-30 | $0.00 10-K · filed 2024-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |